KrisMichaelMahadeoMDMPH
Pediatric Hematology & Oncology • Durham, NCSection Chief Stem Cell Transplantation and Cellular Therapy
Dr. Mahadeo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2400 Pratt St
Durham, NC 27705Phone+1 919-668-1100
Education & Training
Duke University HospitalFellowship, Blood & Bone Marrow Transplant, 2010 - 2011
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Saint Peter's University HospitalResidency, Pediatrics, 2005 - 2007
Maimonides Medical CenterInternship, Transitional Year, 2004 - 2005
St. George's University School of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2017 - 2026
CA State Medical License 2011 - 2025
NC State Medical License 2010 - 2025
NY State Medical License 2007 - 2025
NJ State Medical License 2005 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors Start of enrollment: 2015 Sep 01
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer Start of enrollment: 2021 Jan 14
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- 1 citationsRetrospective Review of Flexible Bronchoscopy in Pediatric Cancer Patients.Ali H Ahmad, Brandon D Brown, Clark R Andersen, Kris M Mahadeo, Demetrios Petropolous
Frontiers in Oncology. 2021-01-01 - 13 citationsRisk Factors for Noninvasive Ventilation Failure in Children Post-Hematopoietic Cell TransplantCourtney M. Rowan, Julie C. Fitzgerald, Asya Agulnik, Matt S. Zinter, Matthew Sharron
Frontiers in Oncology. 2021-05-27 - 26 citationsImmune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize E...Brandon Douglas Brown, Francesco Paolo Tambaro, Mira A. Kohorst, Linda Chi, Kris M. Mahadeo
Frontiers in Oncology. 2021-01-01
Journal Articles
- Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell TherapyKris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
Abstracts/Posters
- Sinusoidal Obstructive Syndrome Among Pediatric and Adolescent and Young Adult Patients: Analysis of Pediatric EBMT Diagnostic and Severity Criteria at MD AndersonKris Michael Mahadeo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...Kris Michael Mahadeo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Authored Content
- ASBMT: A Model for Medical Self-GovernanceFebruary 2018
- ASBMT: A Model for Medical Self-GovernanceFebruary 2018
Press Mentions
- Novel Leukaemia Therapy Aims to Treat Sick Kids Before Time Runs OutNovember 14th, 2022
- New Leukemia Therapy Aims to Treat Sick Children Before It's Too LateOctober 31st, 2022
Groups Release Guidelines for CAR T Treatment in ChildrenAugust 10th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
